Brian K Goodger

Brian K. Goodger serves as a procurement professional responsible for managing complex acquisitions within the biomedical and scientific services sector. Though his official title and agency are not specified, his contracting activity centers on high-stakes technical procurements requiring specialized regulatory and scientific expertise. He routinely handles contracts for the development and manufacturing of biological products and pharmaceutical preparations, often involving stringent compliance with FDA standards and Good Manufacturing Practices. His role supports mission-critical public health objectives by ensuring timely access to advanced therapeutics and specialized scientific services, positioning him as a key liaison between federal requirements and advanced biopharmaceutical capabilities. Goodger’s contractor relationships are primarily with firms possessing deep technical capabilities in biological product manufacturing, pharmaceutical formulation, and professional scientific services. While no specific vendors are identified in the data, his procurement patterns suggest consistent engagement with mid- to large-scale manufacturers and contract research organizations that meet cGMP and quality system requirements. He maintains a vendor ecosystem focused on technical excellence and regulatory compliance, favoring partners with proven track records in sterile production, clinical-grade synthesis, and analytical validation. Goodger’s contracting portfolio is entirely non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic emphasis on technical capability over socioeconomic preferences, indicating a procurement approach prioritizing mission-critical performance, product safety, and scientific rigor over socioeconomic targeting. While small business participation is not formally encouraged through set-asides, his acquisitions may still include small businesses that meet stringent technical thresholds. His primary NAICS focus lies in Biological Product Manufacturing (325414), followed by Pharmaceutical Preparation Manufacturing (325412) and All Other Professional, Scientific, and Technical Services (541990). This underscores his domain expertise in biologics development, drug formulation, and specialized scientific consulting—particularly in areas requiring advanced laboratory validation, process scale-up, and regulatory documentation. His work bridges the gap between cutting-edge biotechnology and federal procurement compliance.